Published in Neurotox Res on September 14, 2010
Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem (2007) 1.88
Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Res (2007) 0.94
Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox Res (2004) 0.94
Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory. Neurotox Res (2011) 0.90
Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues. Neurochem Res (2010) 0.88
Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring. Neurochem Res (2007) 0.87
Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update. Neurotox Res (2015) 0.86
Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression. Eur J Neurosci (2004) 0.86
The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism. Neurotox Res (2008) 0.86
Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders. Neurotox Res (2007) 0.86
Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism. Eur J Pharmacol (2010) 0.86
Increased serum complement C3 and C4 concentrations and their relation to severity of chronic spontaneous urticaria and CRP concentration. J Inflamm (Lond) (2013) 0.86
Influence of physical exercise on neuroimmunological functioning and health: aging and stress. Neurotox Res (2010) 0.85
Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability. Neurotox Res (2008) 0.84
8-hydroxy-2'-deoxyguanosine in colorectal adenocarcinoma--is it a result of oxidative stress? Med Sci Monit (2013) 0.84
A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. Neurotox Res (2014) 0.83
Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism. Pol Arch Med Wewn (2008) 0.83
[Selenium plasma concentrations in children with celiac disease in different stages of diagnosis]. Pol Merkur Lekarski (2002) 0.82
Alternating extremely low frequency magnetic field increases turnover of dopamine and serotonin in rat frontal cortex. Bioelectromagnetics (2004) 0.82
32P liquid sources--comparison of the effectiveness of postangioplasty versus poststenting intravascular brachytherapy in hypercholesterolemic rabbits. Adjunctly implanted titanium stent does not attenuate the effect of endovascular irradiation. Cardiovasc Radiat Med (2003) 0.82
Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise. Neurotox Res (2008) 0.82
Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum. Neurotox Res (2008) 0.81
Effects of diuretic-induced hypovolemia/isosmotic dehydration on cardiorespiratory responses to hyperthermia and its physical treatment in rabbits. Int J Hyperthermia (2006) 0.81
Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression. Neurotox Res (2010) 0.81
Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats. Pharmacol Biochem Behav (2002) 0.81
Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. Regul Pept (2004) 0.81
Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder. Neurotox Res (2015) 0.80
Neurotoxins and neurotoxicity mechanisms. An overview. Neurotox Res (2006) 0.80
Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotox Res (2007) 0.80
Acute L: -DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats. Neurotox Res (2009) 0.79
Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions. Neurotox Res (2011) 0.79
Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res (2007) 0.79
Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. Neurotox Res (2007) 0.78
Histamine in idiopathic inflammatory bowel diseases--not a standby player. Folia Med Cracov (2005) 0.78
Histaminergic activity in a rodent model of Parkinson's disease. Neurotox Res (2009) 0.78
Effect of prenatal manganese intoxication on [(3)H]glucose uptake in the brain of rats lesioned as neonates with 6-hydroxydopamine. Pharmacol Rep (2009) 0.78
Desensitization of 5-HT(1A) autoreceptors induced by neonatal DSP-4 treatment. Eur Neuropsychopharmacol (2006) 0.77
Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control. Neurotox Res (2008) 0.77
Trimetazidine increases [3H]glucose uptake in rat brain. Pharmacol Rep (2006) 0.77
Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats. Neurotox Res (2012) 0.77
Staging neurological disorders: expressions of cognitive and motor disorder. Neurotox Res (2009) 0.77
The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. Eur J Neurosci (2006) 0.77
Gestational manganese intoxication and anxiolytic-like effects of diazepam and the 5-HT1A receptor agonist 8-OH-DPAT in male Wistar rats. Pharmacol Rep (2010) 0.77
Effect of prenatal lead exposure on nigrostriatal neurotransmission and hydroxyl radical formation in rat neostriatum: dopaminergic-nitrergic interaction. Toxicology (2008) 0.77
Influence of central noradrenergic system lesion on the serotoninergic 5-HT3 receptor mediated analgesia in rats. Adv Clin Exp Med (2013) 0.77
Proteinous amino acids in muscle cytosol of rats' heart after exercise and hypoxia. Receptors Channels (2003) 0.77
Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats. Cerebellum (2011) 0.77
Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels. Eur J Pharmacol (2006) 0.77
Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model. Dev Neurosci (2012) 0.77
Dopamine receptor supersensitivity: an outcome and index of neurotoxicity. Neurotox Res (2003) 0.77
Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res (2007) 0.76
Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine. Neurotox Res (2010) 0.76
Biogenic amines in striatum of rats that had been treated with ethanol, and their brains later stored in different temperatures. Receptors Channels (2003) 0.76
Glycogen synthase kinase 3β and its phosphorylated form (Y216) in the paraquat-induced model of parkinsonism. Neurotox Res (2010) 0.76
Neonatal N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) treatment modifies the vulnerability to phenobarbital- and ethanol-evoked sedative-hypnotic effects in adult rats. Pharmacol Rep (2008) 0.76
Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease. Neurotox Res (2011) 0.76
Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats. Neurotox Res (2008) 0.76
Epigenetics and biomarkers in the staging of neuropsychiatric disorders. Neurotox Res (2010) 0.76
Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum. Neurotoxicol Teratol (2006) 0.76
Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists. Pharmacol Rep (2009) 0.76
Gene-environment interplay in neurogenesis and neurodegeneration. Neurotox Res (2004) 0.76
[Molecular mechanisms of levodopa action in animal models of Parkinson's disease]. Neurol Neurochir Pol (2007) 0.76
DSP-4 prevents dopamine receptor priming by quinpirole. Pharmacol Biochem Behav (2006) 0.76
Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine. Pharmacol Rep (2005) 0.76